Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

New Strong Sell Stocks For March 25th

Published 03/24/2019, 10:42 PM
Updated 07/09/2023, 06:31 AM

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

21Vianet Group, Inc. (NASDAQ:VNET) is a provider of carrier-neutral Internet data center services. The Zacks Consensus Estimate for its current year earnings has been revised 100% downward over the last 30 days.

Aegion Corporation (NASDAQ:AEGN) is a provider of technology used in the maintenance, rehabilitation and strengthening of infrastructure. The Zacks Consensus Estimate for its current year earnings has been revised 10.2% downward over the last 30 days.

Champions Oncology, Inc. (NASDAQ:CSBR) is a developer of technology solutions used in personalizing the development and use of oncology drugs. The Zacks Consensus Estimate for its current year earnings has been revised 8.3% downward over the last 30 days.

Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) is the owner and operator of a clinical stage biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 15.3% downward over the last 30 days.

Cross Country Healthcare, Inc. (NASDAQ:CCRN) is a provider of healthcare staffing, recruiting and workforce solutions. The Zacks Consensus Estimate for its current year earnings has been revised 66.7% downward over the last 30 days.

View the entire Zacks Rank #5 List.



21Vianet Group, Inc. (VNET): Free Stock Analysis Report

Aegion Corporation (AEGN): Free Stock Analysis Report

Concert Pharmaceuticals, Inc. (CNCE): Free Stock Analysis Report

Champions Oncology, Inc. (CSBR): Free Stock Analysis Report

Cross Country Healthcare, Inc. (CCRN): Free Stock Analysis Report

Original post
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.